CORRECTION OF THE EMETIC SYNDROME IN CASE OF THE CHEMOTHERAPY-Reference-Cited by-同舟云学术

CORRECTION OF THE EMETIC SYNDROME IN CASE OF THE CHEMOTHERAPY

Published:2019-10-30 Issue:gec22-01 Volume: Page:29-34
ISSN:2709-1783
Container-title:SWorld-Ger Conference proceedings
language:
Short-container-title:gec

Author:

Borysenko Dmytro^ORCID,Maikut-Zabrodskaja Ivanna^ORCID,Melnyk Ulyana,Vydyborets Stanislav^ORCID

Abstract

У статті представлено механізми розвитку нудоти та блювання у пацієнтів, які отримують цитостатичну терапію та наведені сучасні методи їх профілактики і лікування. Mechanisms of development of nausea and vomiting at patients which get cytostatic therapy a

Publisher

Sergeieva I

Reference12 articles.

1. Bajdurin SA. Klinicheskaja gematologija: rukovodstvo dlja vrachej. Каraganda: АКНYР, 2018: 400 p.

2. Berger A.M., Clark-Snow R.A. Adverse effects of treatment. In: DeVita V.T. Jr, Hellman S., Rosenberg S. eds. Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins. 2001. P.2869-2880.

3. Blower P, Aapro M. Granisetron vs ondansetron: is it a question of duration of 5-HT3 receptor blockade? Br. J. Cancer. 2002. Vol.86. P.1662–1663.

4. Diemunsch P., Grelot L. Potential of substance P antagonists as antiemetics. Drugs. 2000. Vol.60. P.533-546.

5. Gralla R.J. Antiemetic treatment for cancer chemotherapy: problems and progress. Support Care Cancer. 1994. Vol.2. P.275–276.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in Neoplastic Disease: Current Treatment Options;Family medicine. European practices;2023-02-28